Clinical Trial Details
— Status: Withdrawn
Administrative data
NCT number |
NCT00766259 |
Other study ID # |
Eng-MRSA |
Secondary ID |
|
Status |
Withdrawn |
Phase |
|
First received |
|
Last updated |
|
Start date |
July 2009 |
Est. completion date |
June 2012 |
Study information
Verified date |
March 2021 |
Source |
Veterans BioMedical Research Institute |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
Inpatients will be prospectively have nares screened and MRSA strains collected. All clinical
MRSA strains of patients will also be prospectively collected. A sensitive strain
discrimination test of spa typing will be used to determine if the strains are related.
Hypotheses are
1. Strain colonization durations vary and may be very short in days to weeks.
2. Colonizing strains rarely infect 3) Both 1 and 2 may be affected by the patient's
co-morbidity.
Description:
Patients of special interest:
1. Skin and soft tissue infection
2. Nursing home patients
3. Vascular patients with leg lesions
4. ICU patients
5. Hemodialysis patients
6. Outpatients without history of infections(controls) will have nares screened for MRSA
and then monthly for 1 year.
All strains will be saved and spa typed. Analysis of the data will be performed to answer the
questions and hypotheses and to answer is the screening effort and the isolation of patients
for MRSA as is in current practice worthwhile and is there any scientific data to support
this practice